Synovial cytokine and growth factor regulation of MMPs/TIMPs: Implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 619-621

  Fearon, U ^a   Reece, R ^a   Smith, J ^a   Emery, P ^a   Veale, D J ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; ARTHROSCOPY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0032864718     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07743.x     Document Type: Conference Paper

References (12)

1. 1. Espinoza, L.R., F.B. Vasey, C.G. Espinoza, T.S. Bocanegra & B.F. Germain. 1982. Vascular changes in psoriatic synovium. Arthritis Rheum. 25: 677-684.
2. 2. Veale, D., G. Yanni, S. Rogers, L. Barnes, B. Bresnihan & O. FitzGerald. 1993. Reduced synovial macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis compared to rheumatoid arthritis. Arthritis Rheum. 36(7): 893-900.
3. 3. Jones, S.M., J. Dixey, N.D. Hall & N.J. McHugh. 1997. Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of pateints with psoriatic arthritis. Br. J. Rheumatol. 36(7): 748-757.
4. 4. Reece, R., J.D. Canete, P. Emery & D.J. Veale. 1998. Inter-observer reliability of arthroscopic synovitis grading in inflammatory arthritis (abstr.) Br. J. Rheumatol. 37: 31.
5. 5. Handel, M.L., L.B. McMorrow & E.M. Gravallese. 1995. Nuclear factor-κB in rheumatoid synovium: localisation of p50 and p65. Arthritis Rheum. 38: 1762-1770.
6. 6. Blake, D.R., P.G. Winyard & R. Marok. 1994. The contribution of hypoxic-reperfusion injury to inflammatory synovitis: the influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann. N.Y. Acad. Sci. 723: 308-317.
7. 7. Lotz, M. & P.-A. Guerne. 1991. Interleukin-6 enhances the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity. J. Biol. Chem. 266: 2017-2020.
8. 8. Langdon, C., J. Leith, F. Smith & C.D. Richards. 1997. Oncostatin M stimulates monocyte chemoattractant protein-1 and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum. 40: 2139-2146.
9. 9. Folkman, J. & P.A. D'Amore. 1996. Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155.
10. 10. Stahl, N., T.G. Boulton, T. Farruggella, N.Y. Ip, S. Davis, B.A. Witthuhn, F.W. Quelle, O. Silvennoinen, G. Barbieri, S. Pellegrini, J.N. Ihle & G.D. Yancopoulos. 1994. Association and activation of JAK-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263: 92-95.
11. 11. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, A.S. Baldwin, JR. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270: 283-286.
12. 12. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg & M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NFκB activity through induction of IκBα synthesis. Science 270: 286-290.